Nightingale Health
Company profile
About Nightingale Health
Nightingale Health's mission is to build sustainable healthcare and reduce health inequalities. The company has developed the world's most advanced health check for the health industry, providing risk detection for multiple chronic diseases from a single blood sample. Their solution can be scaled to entire populations at a low cost and can replace many current risk assessments. This innovative approach enables effective targeting and tracking of health interventions, aiming to prevent the onset of chronic diseases, thereby creating a healthier world.
Nightingale Health operates globally with its parent company based in Finland and seven subsidiaries in countries including Japan, the United States, Singapore, and the United Kingdom. They serve customers in more than 25 countries across healthcare and medical research sectors. Their technology is utilized in leading global health initiatives such as the UK Biobank, supported by over 600 peer-reviewed publications validating their technology.
Milestones
Key milestones include:
- 2025: Nasdaq Helsinki approved their listing application on the Main Market; trading commenced on 19 March 2025 with the code HEALTH. Trading in B shares and ADRs began on OTCQX International Market in the US on 21 March 2025.
- 2024: Collaborations announced with organizations like Kaiser Foundation, ZOE, Boston Heart Diagnostics, 23andMe, and Phenome Health. Opened a new laboratory in the UK and planned a laboratory opening in the US. Completed analysis of blood samples from all 500,000 UK Biobank participants.
- 2023: Partnership with Suomen Terveystalo Oy for nationwide occupational healthcare in Finland; remote blood collection kit launched for research and clinical trials; collaboration with Innoquest Diagnostics.
- 2022: Launched the direct-to-consumer service Livit by Nightingale Health and expanded into genetics with an international center for genomic data analysis.
- 2019-2021: Expanded operations to Japan and the US, setting up laboratories and offices, listed Series B shares on Nasdaq Helsinki First North Growth Market, and raised significant funding.
- Company founded in 2013, based on scientific innovation of a blood test detecting various molecules from a single sample, continuously supported by scientific research and publications.
Global Presence
The Nightingale Health Group includes offices and laboratories in Finland (HQ & Laboratory), Estonia, Germany, Japan, Singapore, Sweden, United Kingdom, and the United States.
Careers and Opportunities
Nightingale Health invites people to build sustainable healthcare together. Their team comprises diverse professionals such as data scientists, software developers, designers, marketers, salespeople, and more, united by a mission to bring preventative healthcare within everyone's reach.
They offer remote working possibilities, premium insurance, massage services, commuting benefits, dental care, sports and culture benefits, an in-house chef and café, and interest clubs including a band.
Social Media and Contact
LinkedIn: https://www.linkedin.com/company/nightingalehealth/
Official website: https://nightingalehealth.com/
